+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Denmark

  • ID: 4861662
  • Report
  • September 2019
  • Region: Global, Denmark
  • 84 Pages
  • FinGlobe, Inc

FEATURED COMPANIES

  • Aarhus University
  • Bioneer A/S
  • Evosep Biosystems
  • LEO Pharma A/S
  • Orphazyme A/S
  • Stenocare A/S
  • MORE
This trends report provides comprehensive analysis on all licensing deals and negotiations reported for the healthcare companies of Denmark during January 1, 2018 to August 31, 2019, categorized and summarized by various important aspects such as healthcare sub-sectors, market capitalization groups, medicine groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of Denmark.

Analytical data coverage:
  • January 1, 2018 to August 31, 2019 licensing deals and negotiations
  • 120+ healthcare licensing news of 50+ companies of Denmark
  • Small-mid-large cap companies covered-LargeCap (16%), SmallCap (7%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered-Pharmaceuticals (29%), Biotech (42%), Medical Devices (11%), Healthcare Services (18%)
  • 14 medicine groups studied-Endocrinology (17%), Dermatology (15%), Oncology (14%)
  • 8+ variables analyzed
Key Features:
  • 20 months’ healthcare licensing transactions of Denmark analyzed at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized
The Report is useful to:
  • Healthcare companies of Denmark planning to introduce products in other countries
  • Companies active in R&D and seeking new market base
  • Healthcare company executives of Denmark negotiating licensing deals
  • Investors analyzing varied kinds of transaction options for licensing deals in Denmark
Key analysis provided: January 2018-August 2019
  • Total number of licensing deals signed by companies of Denmark
  • Total number of companies/institutes of Denmark involved in the licensing deals
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aarhus University
  • Bioneer A/S
  • Evosep Biosystems
  • LEO Pharma A/S
  • Orphazyme A/S
  • Stenocare A/S
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions of Denmark licensed during last twenty months
1.1 Healthcare sub-sectors with most licensing deals
1.2 Market capitalization groups with most licensing deals
1.3 Medicine groups most active in licensing deals
1.4 Licensing payment arrangements most followed
1.5 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals of Denmark by key attributes during last twenty months
2.1 For each of the healthcare sub-sectors
2.2 For each of the marketcap groups
2.3 For each of the medicine groups
2.4 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed for Denmark during last twenty months - By company name
Appendix 2 List of companies/institutes covered - By company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By company name
Appendix 6 List of not-for-profit groups covered - By institute name
Appendix 7 List of companies/institutes covered - By medicine group and company name
Appendix 8 List of companies/institutes covered - By terms of payment and company name
Appendix 9 Licensing deals discontinued for Denmark during last twenty months
Note: Product cover images may vary from those shown
  • Aarhus University
  • Advalight Aps
  • ALK-Abelló A/S
  • Ambu A/S
  • Amgros I/S
  • Ascendis Pharma A/S
  • Bavarian Nordic AS
  • Biocare Copenhagen A/S
  • Bioneer A/S
  • Bioporto A/S
  • Chr Hansen Holding A/S
  • COBO Technologies Aps
  • Coloplast A/S
  • Cryos International Sperm and Egg Bank
  • Curatec Nordic
  • Danavian Cannabis Ltd.
  • Danish Breast Cancer Cooperative Group
  • Endoca
  • Evosep Biosystems
  • ExpreS2ion Biotech Holding AB
  • Genmab A/S
  • GN Hearing A/S
  • Gubra
  • H. Lundbeck A/S
  • Hoba Therapeutics Aps
  • Immudex
  • Initiator Pharma A/S
  • LEO Pharma A/S
  • Liva Healthcare
  • Lundbeck Export A/S
  • Novo Nordisk A/S
  • Novo Nordisk Pharmatech A/S
  • Novozymes A/S
  • Nuevolution AB
  • Oncology Venture A/S
  • Orifarm Group A/S
  • Orphazyme A/S
  • Pharma Medico Aps
  • Pharmacosmos A/S
  • Radiometer Medical Aps
  • Saniona AB
  • Scandion Oncology A/S
  • Schroll Medical Aps
  • Solural Pharma Aps
  • Stenocare A/S
  • Symphogen A/S
  • University Hospital Bispebjerg
  • University of Copenhagen
  • Vectron Biosolutions AS
  • Virogates A/S
  • Visiopharm A/S
  • William Demant Holding
  • Xellia Pharmaceuticals Aps
  • Zealand Pharma A/S
  • Zealand University Hospital
Note: Product cover images may vary from those shown
Adroll
adroll